121 In the index

GHRP-2 GHRP-2

A lab-made peptide that strongly triggers growth hormone release and increases appetite, studied in human hormone research. Studies confirm both effects are real and reliable, but it has never gone through a full trial program needed for drug approval.

Also known as Pralmorelin, pralmorelina, pralmoreline, E6S6E1F19M, KP 102, Ala-beta-Nal-Ala-Trp-Phe-Lys-NH2, pralmorelinum, RefChem:175716

Effects Build muscle

Routes Subcutaneous

Legal status Research chemical

WADA Banned at all times

Molecular Structure of C₄₅H₅₅N₉O₆

Drag to rotate · scroll to zoom

PubChem has no 3D conformer for this molecule, so this is the flat structure.

Chemistry

Formula: C45H55N9O6
Molar mass: 818.0
CAS: 158861-67-7
PubChem CID: 6918245
IUPAC name: (2S)-6-amino-2-[[(2R)-2-[[(2S)-2-[[(2S)-2-[[(2R)-2-[[(2R)-2-aminopropanoyl]amino]-3-naphthalen-2-ylpropanoyl]amino]propanoyl]amino]-3-(1H-indol-3-yl)propanoyl]amino]-3-phenylpropanoyl]amino]hexanamide
InChIKey: HRNLPPBUBKMZMT-RDRUQFPZSA-N

Reported dosing

User-reported

What has been reported in the literature and by users. This is a record of what is done, not a recommendation.

Typical dose 100-200 mcg per dose

Reported range 100-300 mcg per dose

Route Subcutaneous injection

Frequency 1-3 times daily

Duration 8-12 week course (unregulated use)

Not FDA-approved as a marketed drug; sold only as a research chemical, with dosing derived from small clinical studies and vendor/forum reports rather than approved labeling.

Where this comes from Small published clinical studies; user-reported/research-chemical vendor literature

There is no approved human dosing for this compound. The figures above are what users and vendors report, not what has been established as safe or effective. Treat them as a record of what is done, not as guidance.